WOBURN, Mass.–(BUSINESS WIRE)–BioProcess Technology Consultants Inc. (BPTC) announced today the
closing of its acquisition by BDO USA, LLP, one of the nation’s leading
professional services organizations. The acquisition combines BPTC’s
broad chemistry, manufacturing and controls (CMC) consulting services
with BDO’s existing capabilities in the life sciences and
biopharmaceutical industries.
Founded in 1994, BPTC was a biologics CMC consulting firm, providing a
full range of technical, regulatory, and strategic assistance related to
the development and commercialization of biopharmaceutical products.
BPTC assisted clients in developing manufacturing processes and
strategies that enhanced the overall value of their products, while
de-risking product development.
Howard L. Levine, Ph.D., BPTC founder, president and CEO will become
managing director and national leader of the Bioprocess Technology Group
(BPTG) within BDO’s Life Sciences practice and the majority of BPTC’s
consultants will join the new BPTG. “Since our inception, we’ve worked
with companies to advance and de-risk the biotherapeutic development
process, address unmet medical needs and increase patient access to
novel medicines,” said Levine. “We’re excited to join BDO’s Life
Sciences practice to support clients across the entire product
development and company lifecycles.”
“We are pleased to welcome BPTC’s knowledge and resources to enhance our
focus in the life sciences industry and deepen our biopharmaceutical
product development offerings,” said Eric Jia-Sobota, national leader of
BDO’s Industry Specialty Services and Life Sciences practices. “Joining
forces with BPTC strengthens our ability to assist life sciences
companies in managing risk, maximizing profitability and fostering
continued innovation to unlock new value and deliver improved outcomes.”
About BioProcess Technology Consultants
BPTC is the recognized worldwide leader in biologics CMC consulting,
providing a full range of technical, regulatory, and strategic
assistance to pharmaceutical and biotechnology companies in the
development and commercialization of biopharmaceutical products. The
company works with clients globally to find and apply solutions to the
challenges of biopharmaceutical product development from clone to
commercial®. BPTC helps develop
manufacturing processes and strategies that enhance the overall value of
client companies, de-risk biopharmaceutical development, and accelerate
the advancement of new products from clone to clinic®.
BPTC also helps investors, service providers, and companies make
informed decisions by providing technical due diligence services and
business evaluations of new products as well as technologies for product
discovery, development, or commercialization. For more information about
BPTC, visit http://www.bptc.com.
Follow us on Twitter at @bptcglobal or LinkedIn at http://www.linkedin.com/company/bioprocess-technology-consultants-inc.
About BDO USA
BDO USA, LLP is a U.S. professional services firm providing assurance,
tax, and advisory services to a wide range of publicly traded and
privately held companies. For more than 100 years, BDO has provided
quality service through the active involvement of experienced and
committed professionals. The firm serves clients through more than 60
offices and over 650 independent alliance firm locations nationwide. As
an independent Member Firm of BDO International Limited, BDO serves
multi-national clients through a global network of more than 80,000
people working out of 1,591 offices across 162 countries. BDO USA, LLP
is the U.S. member of BDO International Limited, a UK company limited by
guarantee, and forms part of the international BDO network of
independent member firms. BDO is the brand name for the BDO network and
for each of the BDO Member Firms. For more information please visit: www.bdo.com.
Contacts
Al Doig
781-640-0627
adoig@bdo.com